Analgesia After Total Knee Replacement Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01489631 |
Recruitment Status
:
Completed
First Posted
: December 9, 2011
Last Update Posted
: June 8, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Postoperative pain after total knee replacement surgery is difficult to treat. Mobilisation and hospital discharge might be delayed. Recent research shows that intra-articular infiltration with local anesthetics and perioperative prescription of gabapentin can improve outcome.
Objective of the study: Comparison of mobilisation speed and postoperative NRS-scores of patients after total knee replacement surgery which is treated with epidural analgesia or peroperative infiltration of the knee. Appraisal of the value of gabapentin for reduction of postoperative opiate consumption.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Total Knee Arthroplasty | Drug: naropin Drug: marcaine Drug: sufentanil Drug: neurontin | Not Applicable |
Study design:
Prospective randomised study
Study population:
Patients aged eighteen years or older, in whom knee replacement surgery is indicated. They will have spinal anaesthesia and epidural analgesia if indicated by randomisation. They must not have contraindications for epidural analgesia or the used medication in this study.
Intervention:
The first group will be treated with epidural analgesia. Before surgery the epidural catheter will be placed according to local guidelines. After the operation epidural infiltration with bupivacaine and sufentanil will be commenced. The second group will receive local infiltration with ropivacaine of the knee during surgery. Half of these patients will additionally be treated with gabapentin.
Primary study parameters/outcome of the study:
NRS-score (11-scale Numeric Rating Scale in which 0 means no pain, and 10 means most pain imaginable) in rest.
Secondary study parameters/outcome of the study:
Speed of mobilisation, postoperative opiate consumption. NRS scores during flexion exercise of the knee and during walking exercise.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 81 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Comparison of Intra-articular Infiltration and Gabapentin With Epidural Analgesia After Total Knee Replacement Surgery |
Study Start Date : | March 2013 |
Actual Primary Completion Date : | April 2014 |
Actual Study Completion Date : | April 2014 |

Arm | Intervention/treatment |
---|---|
Active Comparator: epidural analgesia
The first group will be treated with epidural analgesia. Before surgery the epidural catheter will be placed according to local guidelines. After the operation epidural infiltration with bupivacaine and sufentanil will be commenced.
|
Drug: marcaine
bupivacaine 0,125%
Other Name: bupivacaine
Drug: sufentanil
sufentanil 1mcg/ml
Other Name: sufenta forte
|
Active Comparator: local infiltration
The second group will receive local infiltration with ropivacaine of the knee during surgery.
|
Drug: naropin
ropivacaine 0,2%, 3x 50 ml during surgery
Other Name: ropivacaine
|
Active Comparator: local infiltration and gabapentin
The third group will receive local infiltration with ropivacaine of the knee during surgery and will additionally be treated with gabapentin.
|
Drug: naropin
ropivacaine 0,2%, 3x 50 ml during surgery
Other Name: ropivacaine
Drug: neurontin
gabapentin 600 mg pre-operative 3 dd 300 mg
Other Name: gabapentin
|
- NRS score in rest [ Time Frame: 3 days after surgery ]
- Speed of mobilisation [ Time Frame: 3 days after surgery ]
- Postoperative morphine consumption [ Time Frame: 3 days after surgery ]Daily morphine consumption (mg) per day
- NRS score during flexion exercise [ Time Frame: 3 days after surgery ]
- NRS score during walking exercise [ Time Frame: 3 days after surgery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years or older and legally responsible
- Waiting for total knee replacement surgery
- Informed consent
Exclusion Criteria:
- Contraindications for epidural analgesia
- Aortic Valve stenosis
- Severely compromised cardiac function
- infection near epidural punction site
- Redo knee surgery
- Previous arthrotomies
- Allergy/Hypersensitivity for study mediation or all other used medication
- Participation in other studies

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01489631
Netherlands | |
St. Antonius Hospital | |
Nieuwegein, Netherlands, 3430 EM |
Principal Investigator: | Leon Timmerman, MD | Anesthesiologist | |
Principal Investigator: | Louis N Marting, MD | Orthopedic surgeon |
Responsible Party: | Leon Timmerman, anesthesiologist, St. Antonius Hospital |
ClinicalTrials.gov Identifier: | NCT01489631 History of Changes |
Other Study ID Numbers: |
TKP-37796 |
First Posted: | December 9, 2011 Key Record Dates |
Last Update Posted: | June 8, 2015 |
Last Verified: | June 2015 |
Keywords provided by Leon Timmerman, St. Antonius Hospital:
Epidural Local infiltration Knee Arthroplasty |
Additional relevant MeSH terms:
Bupivacaine Ropivacaine Sufentanil Gabapentin gamma-Aminobutyric Acid Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents Analgesics Anticonvulsants Antiparkinson Agents Anti-Dyskinesia Agents |
Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Anti-Anxiety Agents Tranquilizing Agents Psychotropic Drugs Excitatory Amino Acid Antagonists Excitatory Amino Acid Agents Neurotransmitter Agents Antimanic Agents GABA Agents Analgesics, Opioid Narcotics Adjuvants, Anesthesia Anesthetics, Intravenous |